We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
Although there is no curative treatment for lupus, this is effective in practically all cases. The aim is to control the disease with the lowest possible drug dose for the least possible time. In this way, the majority of patients can enjoy a normal life, from a family, occupational, and social point of view.
Information. The patients with lupus and their families must receive adequate and complete information about the disease in order for the patient to cooperate.
Walk, swim, or ride a bicycle.It is advisable to carry out these types of activities in order to prevent the muscle weakness that causes fatigue and alternate them with periods of rest. To carry out a physical activity also helps to cope with situations of physical and mental stress.
Avoid direct exposure to the sun and other light sources. Especially in patients with photosensitivity.
Balanced diet. There is no diet that protects or reduces the activity of the disease. It is recommended to eat foods with a low content of fat, salt, and sugar, and with a high fibre content. Those patients that are taking corticosteroids should limit their intake of sugar, fat and salt. Furthermore, if the kidney is affected or you suffer from high blood pressure, salty foods must be avoided.
Analgesic and anti-inflammatory drugs. These are used in patients with joint or muscular pains.
Anti-malarial drugs. These are drugs prepared to cure malaria. They form the basic treatment and, apart from a contraindication (exceptional), all patients with lupus must be treated with anti-malarial drugs. The most used are hydroxychloroquine, mepacrine, and chloroquine sulphate.
Corticosteroids. The most used is prednisone. They are very effective for reducing lupus activity. Due to the side-effects of the corticosteroids, the aim is to use them at the lowest dose possible and for the least time possible. The dose depends on the severity of the symptoms, and must be gradually decreased whenever possible, withdrawing them once the disease is under control.
Immunosuppressive drugs. They are used in the most severe manifestations, such as kidney or brain involvement, or in those patients who do not tolerate corticosteroids. The most common are methotrexate, azathioprine, cyclophosphamide, and mycophenolate.
Biological therapies. They are those that are prepared from human proteins or live cells, unlike those that are non-biological, that are prepared using a combination of chemical agents. They are currently used for severe cases that do not respond to conventional treatment (antimalarials, corticosteroids and immunosuppressants). The most used are belimumab and rituximab.
In recent years, there has been a considerable increase in the number of clinical trials of new treatments for patient with lupus. The majority are focused on new therapies directed at blocking molecules that intervene in key points of the mechanisms involved in the onset and development of the disease process. The advantage of these new treatments is based on that they are more specific and selective in their mechanism of action, thus, the profile of side-effects is much better than that of conventional treatments (especially corticosteroids and immunosuppressants).
We are sorry, we are working to improve PortalCLÍNIC. Help us become better, tell us why
Thanks for your help!
An error has occurred and we were unable to send your opinion, please try again later.
Substantiated information by:
Gerard Espinosa GarrigaMedical InternistAutoimmune Diseases Department
Irene Teixidó RibaudiObstetrics and GynecologyMaternofetal Medicine Department
José-Manuel Mascaró GalyDermatologistDermatology Department
Luis F Quintana PorrasNephrologistNephrology Department
Neus Guasch PomesNurseAutoimmune Diseases Department
Ricard Cervera SeguraAutoimmune Diseases Head of Department
Published: 20 February 2018
Updated: 20 February 2018
The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.
Receive the latest updates related to this content.
Thank you for subscribing!
If this is the first time you subscribe you will receive a confirmation email, check your inbox
An error occurred and we were unable to send your data, please try again later.